학술논문
Use of disease-modifying drugs (tocilizumab, tofacitinib, and baricitinib—a biological or synthetic target specific) in patients hospitalized with COVID-19
Document Type
Article
Author
Source
In: Revista da Associacao Medica Brasileira . (Revista da Associacao Medica Brasileira, 2022, 68(1):3-8)
Subject
Language
English
ISSN
18069282
01044230
01044230